We at the Nanobiopharmaceutical Design Lab are dedicated to advancing the development of nanobiopharmaceuticals and targeted therapies for the effective treatment of diseases. By harnessing the innovations in nanomedicines and antibody-based therapeutics, our research aims to improve the treatment outcomes by precisely targeting disease specific molecular marker while minimizing systemic side effects.

Through cutting-edge interdisciplinary research, we are focused on designing novel drug delivery systems and therapeutic platforms that respond to specific biological cues within the body.

Our mission is to bridge the gap between bench science and clinical applications, paving the way for next-generation therapies.